Australia
· Delayed Price · Currency is AUD XRF Scientific Statistics
Total Valuation
XRF Scientific has a market cap or net worth of AUD 264.91 million. The enterprise value is 261.35 million.
| Market Cap | 264.91M |
| Enterprise Value | 261.35M |
Important Dates
The next estimated earnings date is Wednesday, August 20, 2025.
| Earnings Date | Aug 20, 2025 |
| Ex-Dividend Date | Sep 12, 2024 |
Share Statistics
XRF Scientific has 140.54 million shares outstanding. The number of shares has increased by 0.94% in one year.
| Current Share Class | 140.54M |
| Shares Outstanding | 140.54M |
| Shares Change (YoY) | +0.94% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | 21.72% |
| Owned by Institutions (%) | 2.12% |
| Float | 93.09M |
Valuation Ratios
The trailing PE ratio is 28.12 and the forward PE ratio is 25.13.
| PE Ratio | 28.12 |
| Forward PE | 25.13 |
| PS Ratio | 4.40 |
| PB Ratio | 4.89 |
| P/TBV Ratio | 7.02 |
| P/FCF Ratio | 28.20 |
| P/OCF Ratio | 25.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.46, with an EV/FCF ratio of 27.82.
| EV / Earnings | 27.76 |
| EV / Sales | 4.34 |
| EV / EBITDA | 16.46 |
| EV / EBIT | 18.29 |
| EV / FCF | 27.82 |
Financial Position
The company has a current ratio of 3.71, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.71 |
| Quick Ratio | 1.79 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.49 |
| Interest Coverage | 58.81 |
Financial Efficiency
Return on equity (ROE) is 18.76% and return on invested capital (ROIC) is 15.42%.
| Return on Equity (ROE) | 18.76% |
| Return on Assets (ROA) | 13.70% |
| Return on Invested Capital (ROIC) | 15.42% |
| Return on Capital Employed (ROCE) | 25.22% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | 196,168 |
| Employee Count | 48 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, XRF Scientific has paid 4.23 million in taxes.
| Income Tax | 4.23M |
| Effective Tax Rate | 30.06% |
Stock Price Statistics
The stock price has increased by +43.51% in the last 52 weeks. The beta is 0.62, so XRF Scientific's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +43.51% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.73 |
| Relative Strength Index (RSI) | 75.38 |
| Average Volume (20 Days) | 231,786 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XRF Scientific had revenue of AUD 60.19 million and earned 9.42 million in profits. Earnings per share was 0.07.
| Revenue | 60.19M |
| Gross Profit | 27.64M |
| Operating Income | 14.29M |
| Pretax Income | 14.06M |
| Net Income | 9.42M |
| EBITDA | 15.11M |
| EBIT | 14.29M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 8.13 million in cash and 4.57 million in debt, giving a net cash position of 3.56 million or 0.03 per share.
| Cash & Cash Equivalents | 8.13M |
| Total Debt | 4.57M |
| Net Cash | 3.56M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 54.21M |
| Book Value Per Share | 0.39 |
| Working Capital | 25.99M |
Cash Flow
In the last 12 months, operating cash flow was 10.37 million and capital expenditures -972,746, giving a free cash flow of 9.39 million.
| Operating Cash Flow | 10.37M |
| Capital Expenditures | -972,746 |
| Free Cash Flow | 9.39M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 45.92%, with operating and profit margins of 23.74% and 15.64%.
| Gross Margin | 45.92% |
| Operating Margin | 23.74% |
| Pretax Margin | 23.36% |
| Profit Margin | 15.64% |
| EBITDA Margin | 25.10% |
| EBIT Margin | 23.74% |
| FCF Margin | 15.60% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.07%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 2.07% |
| Dividend Growth (YoY) | 18.18% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 58.18% |
| Buyback Yield | -0.94% |
| Shareholder Yield | 1.24% |
| Earnings Yield | 3.55% |
| FCF Yield | 3.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XRF Scientific has an Altman Z-Score of 12.48 and a Piotroski F-Score of 6.
| Altman Z-Score | 12.48 |
| Piotroski F-Score | 6 |